Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Cancer Res. 2010 Aug 24;70(18):7264–7272. doi: 10.1158/0008-5472.CAN-10-0820

Table 2. TGCT incidence in M19 mice deficient for Sf1.

M19 (or M19/M19) was crossed to Sf1+/- mice (Supplementary Fig.3). The progeny were genotyped to determine the M19/+ and M19/+;Sf1+/- males. Testes phenotypes of all the males were examined. The significance of the difference in tumor incidences between the strains is P = 0.0375.

Genotype No. with tumors Bilateral tumors Unilateral tumors Normal testes Total number of males examined
M19/+ 36 (27 %) 11 (31%) 25 95 131
M19/+;Sf1+/- 22 (17%) 4 (18%) 18 111 133